Chloe was a project coordinator and research associate from 2018-2021. She worked with Dr. Cameron Myhrvold to investigating CRISPR-based antivirals and diagnostics for diseases like COVID-19 and Influenza.
She graduated from Tufts University in 2018 with a B.S. in both Biology and Community Health. There, she conducted research on a variety of vaccine development programs, both at the Singapore Immunology Network and Massachusetts General Hospital. She also investigated Chagas disease risk and transmission in Costa Rican rainforests.
Chloe is currently pursuing her MD at Weill Cornell Medical College in New York City. Chloe is dedicated to alleviating health disparities on a local and global scale, and aspires to be an infectious disease physician.